세계의 외래 종양학 주입 치료 시장 보고서(2025년)

Outpatient oncology infusion refers to the delivery of cancer-fighting medications in non-hospital settings, such as infusion centers or clinics. This approach aims to offer effective, convenient, and cost-efficient cancer treatment while reducing the need for prolonged hospital stays.

The primary product types used in outpatient oncology infusion include infusion pumps, intravenous (IV) sets, intravenous cannulas, and needleless connectors. Infusion pumps are medical devices that administer precise amounts of fluids-such as medications or nutrients-into a patient's body over a controlled timeframe. These products support various therapies, including chemotherapy, targeted therapy, immunotherapy, and hormonal therapy. They are applied in treating conditions such as lung cancer, liver cancer, breast cancer, prostate cancer, and others, and serve end users such as hospitals, outpatient clinics, and home care settings.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The outpatient oncology infusion market research report is one of a series of new reports from The Business Research Company that provides outpatient oncology infusion market statistics, including the outpatient oncology infusion industry global market size, regional shares, competitors with the outpatient oncology infusion market share, detailed outpatient oncology infusion market segments, market trends, and opportunities, and any further data you may need to thrive in the outpatient oncology infusion industry. This outpatient oncology infusion market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The outpatient oncology infusion market size has grown strongly in recent years. It will grow from $12.99 billion in 2024 to $14.02 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. Growth during the historic period can be attributed to the rising incidence of cancer, the expansion of outpatient care centers, increased patient preference for more comfortable, home-like treatment settings, broader insurance coverage, a shift from inpatient to outpatient care models, and improving cancer survival rates.

The outpatient oncology infusion market size is expected to see strong growth in the next few years. It will grow to $18.81 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. Growth in the forecast period can be attributed to the expanding elderly population, increasing demand for personalized medicine, rising adoption of biosimilars, a stronger focus on cost containment, the shift toward value-based reimbursement models, and ongoing workforce shortages in oncology care. Key trends expected during this period include advancements in infusion device technology, integration of telehealth services, implementation of remote patient monitoring solutions, progress in personalized medicine, and innovations in targeted cancer therapies.

The increasing prevalence of cancer cases is expected to drive the growth of the outpatient oncology infusion market in the coming years. Cancer comprises a range of complex diseases characterized by the uncontrolled growth of abnormal cells that can invade nearby tissues and spread to other parts of the body. The rise in cancer cases is largely due to aging populations globally, as the likelihood of developing cancer increases significantly with age. Outpatient oncology infusion allows for the administration of cancer treatments such as chemotherapy, immunotherapy, or targeted therapy in clinical settings without requiring hospital stays. This enables patients to receive treatment while continuing their daily routines. For example, in April 2024, Macmillan Cancer Support, a UK-based charity supporting people affected by cancer, projected that the number of individuals living with cancer in the UK would surpass 3 million currently, rise to 3.5 million by 2025, 4 million by 2030, and reach 5.3 million by 2040. As a result, the growing prevalence of cancer is fueling demand in the outpatient oncology infusion market.

Companies operating in the outpatient oncology infusion market are developing advanced products such as syringe infusion pumps to improve the accuracy of medication delivery, enhance patient safety, and streamline outpatient cancer care using sophisticated software and dose error reduction systems. Syringe infusion pumps, or syringe drivers, are motorized devices that precisely control fluid delivery by moving the plunger of a syringe at a set rate. For instance, in August 2022, Baxter International Inc., a US-based healthcare company specializing in infusion and surgical technologies, received FDA clearance for its Novum IQ Syringe Infusion Pump (SYR), integrated with Dose IQ Safety Software. This system features a customizable drug library and web-based platform designed to minimize dosing errors and provide clinicians with centralized, real-time access to medication data. Tailored for outpatient settings, including oncology infusion centers, the device delivers accurate and programmable administration of therapeutic agents across a variety of clinical environments.

In March 2022, Fresenius Kabi AG, a Germany-based pharmaceutical company, acquired Ivenix Inc. for $240 million. This acquisition enhances Fresenius Kabi's infusion therapy offerings by adding Ivenix's advanced smart infusion pump technologies to its portfolio. Ivenix Inc., a US-based medical device company, specializes in developing next-generation smart infusion systems used across outpatient and hospital settings, including oncology clinics.

Major players in the outpatient oncology infusion market are Medtronic plc, Becton Dickinson and Company, Baxter International Inc., Fresenius Kabi AG, Terumo Corporation, Nipro Corporation, Smiths Medical Inc., ICU Medical Inc., B. Braun Melsungen AG, InfuSystem Holdings Inc., BPL Medical Technologies Private Limited, Angiplast Private Limited, Bio-Med Healthcare Products Private Limited, Lars Medicare Private Limited, Micrel Medical Devices S.A., AKAS Infusions Private Limited, Mais India Medical Devices Private Limited, Wellead Medical Co. Ltd., AdvaCare Pharma USA LLC, and Polymed Medical Devices Private Limited.

North America was the largest region in the outpatient oncology infusion market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in outpatient oncology infusion report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the outpatient oncology infusion market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The outpatient oncology infusion market consists of revenues earned by entities by providing services such as hormone therapy infusions, supportive care infusions, patient monitoring, patient education, and counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. The outpatient oncology infusion market also includes sales of biosimilars, immunotherapy agents, supportive care drugs, infusion bags, IV poles, and stands. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Outpatient Oncology Infusion Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on outpatient oncology infusion market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for outpatient oncology infusion ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The outpatient oncology infusion market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Infusion Pumps; Intravenous Sets; Intravenous Cannulas; Needleless Connectors
• 2) By Therapy: Chemotherapy; Targeted Therapy; Immunotherapy; Hormonal Therapy
• 3) By Application: Lung Cancer; Liver Cancer; Breast Cancer; Prostate Cancer; Other Cancers
• 4) By End-User: Hospitals; Outpatient Clinics; Home Care Settings
• Subsegments:
• 1) By Infusion Pumps: Volumetric Infusion Pumps; Syringe Infusion Pumps; Elastomeric Infusion Pumps; Ambulatory Infusion Pumps; Smart Infusion Pumps
• 2) By Intravenous Sets: Vented IV Sets; Non-Vented IV Sets; Gravity IV Sets; Pump-Compatible IV Sets; Filtered IV Sets
• 3) By Intravenous Cannulas: Peripheral IV Cannulas; Central IV Cannulas; Winged IV Cannulas (Butterfly); Closed IV Cannulas; Safety IV Cannulas
• 4) By Needleless Connectors: Positive Displacement Connectors; Negative Displacement Connectors; Neutral Displacement Connectors; Closed System Transfer Devices (CSTDs); Anti-Reflux Connectors
• Companies Mentioned: Medtronic plc; Becton Dickinson and Company; Baxter International Inc.; Fresenius Kabi AG; Terumo Corporation; Nipro Corporation; Smiths Medical Inc.; ICU Medical Inc.; B. Braun Melsungen AG; InfuSystem Holdings Inc.; BPL Medical Technologies Private Limited; Angiplast Private Limited; Bio-Med Healthcare Products Private Limited; Lars Medicare Private Limited; Micrel Medical Devices S.A.; AKAS Infusions Private Limited; Mais India Medical Devices Private Limited; Wellead Medical Co. Ltd.; AdvaCare Pharma USA LLC; Polymed Medical Devices Private Limited.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Outpatient Oncology Infusion Market Characteristics

3. Outpatient Oncology Infusion Market Trends And Strategies

4. Outpatient Oncology Infusion Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Outpatient Oncology Infusion Growth Analysis And Strategic Analysis Framework

• 5.1. Global Outpatient Oncology Infusion PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Outpatient Oncology Infusion Market Growth Rate Analysis
• 5.4. Global Outpatient Oncology Infusion Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Outpatient Oncology Infusion Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Outpatient Oncology Infusion Total Addressable Market (TAM)

6. Outpatient Oncology Infusion Market Segmentation

• 6.1. Global Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Infusion Pumps
• Intravenous Sets
• Intravenous Cannulas
• Needleless Connectors
• 6.2. Global Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chemotherapy
• Targeted Therapy
• Immunotherapy
• Hormonal Therapy
• 6.3. Global Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lung Cancer
• Liver Cancer
• Breast Cancer
• Prostate Cancer
• Other Cancers
• 6.4. Global Outpatient Oncology Infusion Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Outpatient Clinics
• Home Care Settings
• 6.5. Global Outpatient Oncology Infusion Market, Sub-Segmentation Of Infusion Pumps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Volumetric Infusion Pumps
• Syringe Infusion Pumps
• Elastomeric Infusion Pumps
• Ambulatory Infusion Pumps
• Smart Infusion Pumps
• 6.6. Global Outpatient Oncology Infusion Market, Sub-Segmentation Of Intravenous Sets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Vented IV Sets
• Non-Vented IV Sets
• Gravity IV Sets
• Pump-Compatible IV Sets
• Filtered IV Sets
• 6.7. Global Outpatient Oncology Infusion Market, Sub-Segmentation Of Intravenous Cannulas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Peripheral IV Cannulas
• Central IV Cannulas
• Winged IV Cannulas (Butterfly)
• Closed IV Cannulas
• Safety IV Cannulas
• 6.8. Global Outpatient Oncology Infusion Market, Sub-Segmentation Of Needleless Connectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Positive Displacement Connectors
• Negative Displacement Connectors
• Neutral Displacement Connectors
• Closed System Transfer Devices (CSTDs)
• Anti-Reflux Connectors

7. Outpatient Oncology Infusion Market Regional And Country Analysis

• 7.1. Global Outpatient Oncology Infusion Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Outpatient Oncology Infusion Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Outpatient Oncology Infusion Market

• 8.1. Asia-Pacific Outpatient Oncology Infusion Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Outpatient Oncology Infusion Market

• 9.1. China Outpatient Oncology Infusion Market Overview
• 9.2. China Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Outpatient Oncology Infusion Market

• 10.1. India Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Outpatient Oncology Infusion Market

• 11.1. Japan Outpatient Oncology Infusion Market Overview
• 11.2. Japan Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Outpatient Oncology Infusion Market

• 12.1. Australia Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Outpatient Oncology Infusion Market

• 13.1. Indonesia Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Outpatient Oncology Infusion Market

• 14.1. South Korea Outpatient Oncology Infusion Market Overview
• 14.2. South Korea Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Outpatient Oncology Infusion Market

• 15.1. Western Europe Outpatient Oncology Infusion Market Overview
• 15.2. Western Europe Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Outpatient Oncology Infusion Market

• 16.1. UK Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Outpatient Oncology Infusion Market

• 17.1. Germany Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Outpatient Oncology Infusion Market

• 18.1. France Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Outpatient Oncology Infusion Market

• 19.1. Italy Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Outpatient Oncology Infusion Market

• 20.1. Spain Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Outpatient Oncology Infusion Market

• 21.1. Eastern Europe Outpatient Oncology Infusion Market Overview
• 21.2. Eastern Europe Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Outpatient Oncology Infusion Market

• 22.1. Russia Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Outpatient Oncology Infusion Market

• 23.1. North America Outpatient Oncology Infusion Market Overview
• 23.2. North America Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Outpatient Oncology Infusion Market

• 24.1. USA Outpatient Oncology Infusion Market Overview
• 24.2. USA Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Outpatient Oncology Infusion Market

• 25.1. Canada Outpatient Oncology Infusion Market Overview
• 25.2. Canada Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Outpatient Oncology Infusion Market

• 26.1. South America Outpatient Oncology Infusion Market Overview
• 26.2. South America Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Outpatient Oncology Infusion Market

• 27.1. Brazil Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Outpatient Oncology Infusion Market

• 28.1. Middle East Outpatient Oncology Infusion Market Overview
• 28.2. Middle East Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Outpatient Oncology Infusion Market

• 29.1. Africa Outpatient Oncology Infusion Market Overview
• 29.2. Africa Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Outpatient Oncology Infusion Market Competitive Landscape And Company Profiles

• 30.1. Outpatient Oncology Infusion Market Competitive Landscape
• 30.2. Outpatient Oncology Infusion Market Company Profiles
  • 30.2.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Outpatient Oncology Infusion Market Other Major And Innovative Companies

• 31.1. Nipro Corporation
• 31.2. Smiths Medical Inc.
• 31.3. ICU Medical Inc.
• 31.4. B. Braun Melsungen AG
• 31.5. InfuSystem Holdings Inc.
• 31.6. BPL Medical Technologies Private Limited
• 31.7. Angiplast Private Limited
• 31.8. Bio-Med Healthcare Products Private Limited
• 31.9. Lars Medicare Private Limited
• 31.10. Micrel Medical Devices S.A.
• 31.11. AKAS Infusions Private Limited
• 31.12. Mais India Medical Devices Private Limited
• 31.13. Wellead Medical Co. Ltd.
• 31.14. AdvaCare Pharma USA LLC
• 31.15. Polymed Medical Devices Private Limited

32. Global Outpatient Oncology Infusion Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Outpatient Oncology Infusion Market

34. Recent Developments In The Outpatient Oncology Infusion Market

35. Outpatient Oncology Infusion Market High Potential Countries, Segments and Strategies

• 35.1 Outpatient Oncology Infusion Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Outpatient Oncology Infusion Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Outpatient Oncology Infusion Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer